RECRUITING

Vascular MRI Evaluation in Giant Cell Arteritis (VEGA)

Description

The research study is being conducted to determine the utility of magnetic resonance imaging (MRI) in identifying inflammation of arteries supplying blood to the head, brain, and eyes. The target population includes patient with suspected giant cell arteritis (GCA; temporal arteritis).

Study Overview

Study Details

Study overview

The research study is being conducted to determine the utility of magnetic resonance imaging (MRI) in identifying inflammation of arteries supplying blood to the head, brain, and eyes. The target population includes patient with suspected giant cell arteritis (GCA; temporal arteritis).

Vascular MRI Evaluation in Giant Cell Arteritis (VEGA) Collaborative A Longitudinal Study of Orbital and Cranial Vessel Wall MRI in Giant Cell Arteritis

Vascular MRI Evaluation in Giant Cell Arteritis (VEGA)

Condition
Giant Cell Arteritis
Intervention / Treatment

-

Contacts and Locations

Philadelphia

3400 Civic Center Blvd, Philadelphia, Pennsylvania, United States, 19104

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Age 50 years or older
  • * First presentation of suspected GCA
  • * New or worsening cranial manifestations within 4 weeks of enrollment concerning for active GCA
  • * Elevated CRP greater than 1.0 mg/dl
  • * Plan to undergo temporal artery biopsy or ultrasound for diagnosis
  • * Contra-indication to receiving MRI including:
  • * Absence of cranial symptoms related to GCA (e.g., only large vessel GCA)

Ages Eligible for Study

50 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

University of Pennsylvania,

Rennie Rhee, MD, PRINCIPAL_INVESTIGATOR, University of Pennsylvania

Study Record Dates

2033-07